Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the second quarter of 2026 before the market opens on ...
Earlier this week, Labcorp announced the nationwide availability of ColoSense, the first FDA-approved RNA-based at-home ...
Labcorp Holdings will report its second-quarter results by the end of this month, and analysts are anticipating a ...
Detailed price information for Laboratory Corp of America (LH-N) from The Globe and Mail including charting and trades.
A healthcare company is preparing to pay $35,000,000 to settle a class action lawsuit over a cybersecurity incident that ...
DelveInsight's Oncology-Based In-Vivo CRO Market Insights report provides the current and forecast market analysis, individual leading oncology-based in-vivo CRO companies' market shares, challenges, ...
PeptiDream Inc. ("PeptiDream"), a public biopharmaceutical company based in Kawasai, Japan, focused on the discovery and development of peptide-based therapeutics, announced the appointment of three ...
Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, granted equity awards on June 30, 2026 that were previously approved by the Compensation Committee of its Board ...
Upload a next-generation sequencing report from any lab and get one unified, AMP/ASCO/CAP-tiered, citation-backed read.
1d
Superior Insurance Advisors Publishes Case File on Broker Pay Disclosure and Health-Plan Litigation
Citing the 2021 disclosure law, recent ERISA filings with case numbers, and FTC findings, the case file outlines steps ...
Madison Investments, an investment advisor, released its first-quarter 2026 investor letter for the “Madison Mid Cap Fund”.
Madison Investments, an investment advisor, released its first-quarter 2026 investor letter for the “Madison Mid Cap Fund”.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results